NARCOLEPSY TYPE 1
Clinical trials for NARCOLEPSY TYPE 1 explained in plain language.
Never miss a new study
Get alerted when new NARCOLEPSY TYPE 1 trials appear
Sign up with your email to follow new studies for NARCOLEPSY TYPE 1, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New pill aims to keep narcolepsy patients awake and steady
Symptom relief Not yet recruitingThis study tests whether a new tablet called ALKS 2680 can help adults with narcolepsy type 1 stay awake longer and have fewer sudden muscle weakness episodes (cataplexy). About 150 participants will receive either the study drug or a placebo for 12 weeks. The goal is to see if t…
Matched conditions: NARCOLEPSY TYPE 1
Phase: PHASE3 • Sponsor: Alkermes, Inc. • Aim: Symptom relief
Last updated May 14, 2026 12:06 UTC
-
Nightmare relief for narcolepsy: new therapy shows promise
Symptom relief Not yet recruitingThis study tests a non-drug therapy called Imagery Rehearsal Therapy to see if it can reduce nightmares in adults with narcolepsy. About 80 participants will receive the therapy and complete three assessments. Half get the therapy right away, the other half after a delay. The goa…
Matched conditions: NARCOLEPSY TYPE 1
Phase: NA • Sponsor: University of Utah • Aim: Symptom relief
Last updated May 06, 2026 16:02 UTC